POLICY BRIEFINGS

Recently Introduced Health Legislation

H.Res.967 — Raising awareness of the impact of COVID-19 on bereaved children; Sponsor: Rep. Watson Coleman, Bonnie [D-NJ-12]; Committees: House - Energy and Commerce

H.R.6946 — To amend the Controlled Substances Act with respect to fentanyl-related substances, and for other purposes; Sponsor: Rep. Pappas, Chris [D-NH-1]; Committees: House - Energy and Commerce; Judiciary

H.R.6948 — To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to promulgate rules to update certain regulations relating to human cells, tissues, and cellular and tissue-based products, and for other purposes; Sponsor: Rep. Crenshaw, Dan [R-TX-2]; Committees: House - Energy and Commerce

H.R.6963 — To amend the Federal Food, Drug, and Cosmetic Act to strengthen requirements for postapproval studies for drugs approved using accelerated approval, and for other purposes; Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6]; Committees: House - Energy and Commerce

S.3778 — A bill to amend titles XVIII and XIX of the Social Security Act to make premium and cost-sharing subsidies available to low-income Medicare part D beneficiaries who reside in Puerto Rico or another territory of the United States; Sponsor: Sen. Menendez, Robert [D-NJ]; Committees: Senate – Finance

S.3782 — A bill to prohibit the delivery of opioids by means of the dark web, and for other purposes; Sponsor: Sen. Hassan, Margaret Wood [D-NH]; Committees: Senate – Judiciary

H.R.6972 — To amend the Federal Food, Drug, and Cosmetic Act to establish additional authorities of the Food and Drug Administration regarding the conduct of pediatric investigations of molecularly targeted drugs to treat cancer, and for other purposes; Sponsor: Rep. Butterfield, G. K. [D-NC-1]; Committees: House - Energy and Commerce

H.R.6973 — To amend the Federal Food, Drug, and Cosmetic Act to clarify the conditions under which the Secretary of Health and Human Services can approve generic drug applications with labeling temporarily different than the brand name drug, and for other purposes; Sponsor: Rep. Carter, Earl L. “Buddy” [R-GA-1]; Committees: House - Energy and Commerce

H.R.6980 — To direct the Secretary of Health and Human Services to conduct a pilot program under which the Secretary increases the conduct of unannounced inspections of foreign human drug establishments and evaluates the differences between inspections of domestic and foreign human drug establishments, including the impact of announcing inspections to persons who own or operate foreign human drug establishments in advance of an inspection; Sponsor: Rep. Hudson, Richard [R-NC-8]; Committees: House - Energy and Commerce

H.R.6988 — To amend the Federal Food, Drug, and Cosmetic Act to authorize a program to support the adoption of, and improve the development of, innovative approaches to pharmaceutical product design and manufacturing, and for other purposes; Sponsor: Rep. Levin, Mike [D-CA-49]; Committees: House - Energy and Commerce

H.R.6991 — To establish the policy of the Department of Veterans Affairs on medicinal cannabis, and for other purposes; Sponsor: Rep. Moulton, Seth [D-MA-6]; Committees: House - Veterans’ Affairs

H.R.6996 — To amend the Federal Food, Drug, and Cosmetic Act with respect to the accelerated approval of a product for a serious or life-threatening disease or condition, and for other purposes; Sponsor: Rep. McMorris Rodgers, Cathy [R-WA- 5]; Committees: House - Energy and Commerce

H.Res.974 — Supporting the goals and ideals of National Women and Girls HIV/AIDS Awareness Day; Sponsor: Rep. Lee, Barbara [D-CA-13]; Committees: House - Energy and Commerce; Foreign Affairs.

H.Res.975 — Expressing the mental health impacts of recurrent climate-related disasters on youth; Sponsor: Rep. Thompson, Mike [D-CA-5]; Committees: House - Energy and Commerce

H.R.7006 — To amend the Federal Food, Drug, and Cosmetic Act to improve inspections of foreign drug manufacturing establishments, and for other purposes; Sponsor: Rep. Griffith, H. Morgan [R-VA-9]; Committees: House - Energy and Commerce

H.R.7008 — To improve patient access to emerging medication therapies by clarifying the scope of permitted health care economic and scientific information communications between biopharmaceutical manufacturers and population health decision makers, and for other purposes; Sponsor: Rep. Guthrie, Brett [R-KY-2]; Committees: House - Energy and Commerce

H.R.7011 — To amend title V of the Social Security Act to support stillbirth prevention and research, and for other purposes; Sponsor: Rep. Adams, Alma S. [D-NC-12]; Committees: House - Energy and Commerce

H.R.7032 — To amend section 505(j) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(j)) with respect to a process to inform persons submitting an abbreviated application for a new drug whether the new drug is qualitatively or quantitatively the same as a listed drug, and for other purposes; Sponsor: Rep. Kuster, Ann M. [D-NH-2]; Committees: House - Energy and Commerce

H.R.7035 — To amend the Federal Food, Drug, and Cosmetic Act to require prompt reports of marketing status by holders of approved applications for biological products, and for other purposes; Sponsor: Rep. Manning, Kathy E. [D-NC-6]; Committees: House - Energy and Commerce

H.R.7045 — To eliminate the opt-out for nonfederal governmental health plans; Sponsor: Rep. Porter, Katie [D-CA-45]; Committees: House - Energy and Commerce

H.R.7047 — To amend title III of the Public Health Service Act with respect to the determination by the Secretary regarding certain biosimilar application elements, and for other purposes; Sponsor: Rep. Schrader, Kurt [D-OR-5]; Committees: House - Energy and Commerce

H.R.7048 — To prohibit the Secretary of Veterans Affairs from replacing physician anesthesiologists with certified registered nurse anesthetics under the health care system of the Department of Veterans Affairs, and for other purposes; Sponsor: Rep. Scott, David [D-GA-13]; Committees: House - Veterans’ Affairs

H.R.7051 — To amend titles XVIII and XIX of the Social Security Act to provide for coverage of prescription digital therapeutics under such titles, and for other purposes; Sponsor: Rep. Thompson, Mike [D-CA-5]; Committees: House - Energy and Commerce; Ways and Means

H.R.7053 — To amend title XVIII of the Social Security Act to extend acute hospital care at home waiver flexibilities; Sponsor: Rep. Wenstrup, Brad R. [R-OH-2]; Committees: House - Ways and Means; Energy and Commerce

S.3791 — A bill to amend titles XVIII and XIX of the Social Security Act to provide for coverage of prescription digital therapeutics under such titles, and for other purposes; Sponsor: Sen. Capito, Shelley Moore [R-WV]; Committees: Senate – Finance

S.3792 — A bill to amend title XVIII of the Social Security Act to extend acute hospital care at home waiver flexibilities; Sponsor: Sen. Carper, Thomas R. [D-DE]; Committees: Senate – Finance

S.3793 — A bill to amend title XI of the Social Security Act to recommend the Center of Medicare and Medicaid Innovation test the effect of technology-enabled care interventions in the home to coordinate care over time and across settings, improve quality, and lower costs for certain Medicare Advantage beneficiaries, and for other purposes; Sponsor: Sen. Scott, Tim [R-SC]; Committees: Senate – Finance

S.3796 — A bill to eliminate the opt-out for nonfederal governmental health plans; Sponsor: Sen. Murphy, Christopher [D- CT]; Committees: Senate - Health, Education, Labor, and Pensions

S.3797 — A bill to amend title V of the Social Security Act to support stillbirth prevention and research, and for other purposes; Sponsor: Sen. Merkley, Jeff [D-OR]; Committees: Senate – Finance

S.3799 — A bill to prepare for, and respond to, existing viruses, emerging new threats, and pandemics; Sponsor: Sen. Murray, Patty [D-WA]; Committees: Senate - Health, Education, Labor, and Pensions

S.3800 — A bill to amend to Public Health Services Act to establish and support a network of Centers for Public Health Preparedness and Response; Sponsor: Sen. Marshall, Roger [R-KS]; Committees: Senate - Health, Education, Labor, and Pensions

S.3809 — A bill to require the Comptroller General of the United States to conduct a study relating to COVID-19 immunity resulting from a prior infection, vaccination, or both, and the COVID-19 pandemic; Sponsor: Sen. Braun, Mike [R-IN]; Committees: Senate - Health, Education, Labor, and Pensions

S.3810 — A bill to amend the Countermeasure Injury Compensation Program with respect to COVID-19 vaccines; Sponsor: Sen. Lee, Mike [R-UT]; Committees: Senate - Health, Education, Labor, and Pensions

S.3814 — A bill to moderate biosurveillance capabilities and infectious disease data collection, and improve epidemic forecasting and outbreak analytics; Sponsor: Sen. Hickenlooper, John W. [D-CO]; Committees: Senate - Health, Education, Labor, and Pensions

S.3819 — A bill to establish an Advanced Research Projects Authority for Health within the National Institutes of Health; Sponsor: Sen. Murray, Patty [D-WA]; Committees: Senate - Health, Education, Labor, and Pensions

S.3820 — A bill to amend title 38, United States Code, to increase the rate of pay for certain nurses and other medical positions of the Department of Veterans Affairs, and for other purposes; Sponsor: Sen. Blumenthal, Richard [D-CT]; Committees: Senate - Veterans’ Affairs

March 14, 2022: | Page 1 Page 2 Page 3